| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.8 |